Neurodegeneration 2017
DOI: 10.1002/9781118661895.ch24
|View full text |Cite
|
Sign up to set email alerts
|

Niemann–Pick Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 83 publications
0
2
0
Order By: Relevance
“…Generally, Niemann–Pick disease is initially suspected upon the observation of variable phenotypic manifestations, but the final diagnoses of NPD-A and NPD-B are based on the identification of acid sphingomyelinase deficiency. The definitive diagnosis of NPD-C requires the demonstration of abnormal intracellular cholesterol trafficking by the impaired response to low-density lipoprotein cholesterol loading in cultured fibroblasts ( 11 ).…”
Section: Discussionmentioning
confidence: 99%
“…Generally, Niemann–Pick disease is initially suspected upon the observation of variable phenotypic manifestations, but the final diagnoses of NPD-A and NPD-B are based on the identification of acid sphingomyelinase deficiency. The definitive diagnosis of NPD-C requires the demonstration of abnormal intracellular cholesterol trafficking by the impaired response to low-density lipoprotein cholesterol loading in cultured fibroblasts ( 11 ).…”
Section: Discussionmentioning
confidence: 99%
“…The estimated prevalence of NPC is 1 in 100,000 European births, with Niemann-Pick disease type C1 (NPC1) accounting for 95% of cases, and Niemann-Pick disease type C2 (NPC2), 5% [ 2 , 3 ]. NPC1 arises from a mutation in NPC1, which encodes for a transmembrane protein incorporated into late endosomes [ 4 ]. When NPC1 is dysfunctional, lipids accumulate in the endosomal system of the cell, which precipitates a cascade of cellular events, leading to neuronal death.…”
Section: Introductionmentioning
confidence: 99%